Hypoxia inducible factor-1 protects against COVID-19: A hypothesis

Med Hypotheses. 2020 Oct:143:109857. doi: 10.1016/j.mehy.2020.109857. Epub 2020 May 20.

Authors

Baris Afsar¹, Mehmet Kanbay², Rengin Elsurer Afsar³

Affiliations

¹ Suleyman Demirel University, School of Medicine, Department of Internal Medicine and Nephrology, Turkey. Electronic address: [email protected].
² Koc University, School of Medicine, Department of Internal Medicine and Nephrology, Turkey.
³ Suleyman Demirel University, School of Medicine, Department of Internal Medicine and Nephrology, Turkey.

No abstract available

Publication types

Letter

MeSH terms

Angiotensin-Converting Enzyme 2
Betacoronavirus
COVID-19
Coronavirus Infections / prevention & control*
Ferritins / metabolism
Humans
Hypoxia
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
Models, Theoretical
Pandemics / prevention & control*
Peptidyl-Dipeptidase A / metabolism
Pneumonia, Viral / prevention & control*
Protein Binding
SARS-CoV-2
Treatment Outcome

Substances

HIF1A protein, human
Hypoxia-Inducible Factor 1, alpha Subunit
Ferritins
Peptidyl-Dipeptidase A
ACE2 protein, human
Angiotensin-Converting Enzyme 2